Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction (2019)
- Authors:
- USP affiliated authors: ANTUNES, ALBERTO AZOUBEL - FM ; CERRI, GIOVANNI GUIDO - FM ; SROUGI, MIGUEL - FM
- Unidade: FM
- DOI: 10.1016/j.jvir.2018.11.027
- Subjects: EMBOLIZAÇÃO TERAPÊUTICA; OBSTRUÇÃO URETRAL; INIBIDORES DE ENZIMAS; PRÓSTATA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of vascular and interventional radiology
- ISSN: 1051-0443
- Volume/Número/Paginação/Ano: v. 30, n. 2, p. 228-232, 2019
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
CARDARELLI-LEITE, Leandro et al. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction. Journal of vascular and interventional radiology, v. 30, n. 2, p. 228-232, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jvir.2018.11.027. Acesso em: 01 abr. 2026. -
APA
Cardarelli-leite, L., Assis, A. M. de, Moreira, A. M., Antunes, A. A., Cerri, G. G., Srougi, M., & Carnevale, F. C. (2019). Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction. Journal of vascular and interventional radiology, 30( 2), 228-232. doi:10.1016/j.jvir.2018.11.027 -
NLM
Cardarelli-leite L, Assis AM de, Moreira AM, Antunes AA, Cerri GG, Srougi M, Carnevale FC. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction [Internet]. Journal of vascular and interventional radiology. 2019 ; 30( 2): 228-232.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.jvir.2018.11.027 -
Vancouver
Cardarelli-leite L, Assis AM de, Moreira AM, Antunes AA, Cerri GG, Srougi M, Carnevale FC. Impact of 5-alpha-reductase inhibitors use at the time of prostatic artery embolization for treatment of benign prostatic obstruction [Internet]. Journal of vascular and interventional radiology. 2019 ; 30( 2): 228-232.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.jvir.2018.11.027 - Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization
- Recurrence of Lower Urinary Tract Symptoms Following Prostate Artery Embolization for Benign Hyperplasia: Single Center Experience Comparing Two Techniques
- Effects of prostatic artery embolization on the dynamic component of benign prostate hyperplasia as assessed by ultrasound elastography: a pilot series
- A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH
- Obesity may influence the relationship between sex hormones and lower urinary tract symptoms
- Prostatic Artery Embolization for Treatment of Benign Prostatic Hyperplasia in Patients with Prostates > 90 g: A Prospective Single-Center Study
- Pelvic Arterial Anatomy Relevant to Prostatic Artery Embolisation and Proposal for Angiographic Classification
- Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis
- Clinical, Laboratorial, and Urodynamic Findings of Prostatic Artery Embolization for the Treatment of Urinary Retention Related to Benign Prostatic Hyperplasia. A Prospective Single-Center Pilot Study
- Quality of Life and Clinical Symptom Improvement Support Prostatic Artery Embolization for Patients with Acute Urinary Retention Caused by Benign Prostatic Hyperplasia
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
